May 19, 2023
May 19, 2023 – AbbVie has announced that the U.S. Food and Drug Administration approved Epkinly
(epcoritamab-bysp) injection, a treatment for adult patients with relapsed
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
International Medical Assistance
May 19, 2023
May 19, 2023 - Krystal Biotech, Inc. has announced that the US Food and Drug Administration (FDA) has
approved VyjuvekTM (beremagene geperpavec-svdt) for the treatment
May 18, 2023
May 12, 2023
May 12, 2023 - The FDA approved Astellas’ Veozah (fezolinetant), an oral, nonhormonal agent for the
treatment of moderate to severe vasomotor symptoms (VMS), or hot flashes
May 10, 2023
May 10, 2023 - Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver
innovative therapies and solutions for people affected by rare diseases
May 8, 2023
May 08, 2023 - Eyenovia, Inc. has announced that the U.S. Food and Drug Administration (FDA) has
approved Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic
May 4, 2023
May 4, 2023 - By Ernie Mundell HealthDay Reporter.
Preliminary mortality data for 2022 finds America making its way back from the devastation of the pandemic, with a significant 5.3%
Preliminary mortality data for 2022 finds America making its way back from the devastation of the pandemic, with a significant 5.3%
May 4, 2023
May 4, 2023 - By Cara Murez HealthDay Reporter.
While the typical recommendation is for women to start getting mammograms at age 40, the American College of Radiology has released new guidelines
While the typical recommendation is for women to start getting mammograms at age 40, the American College of Radiology has released new guidelines